An early favorable outcome of streptococcal toxic shock syndrome may require a combination of antimicrobial and intravenous gamma globulin therapy together with activated protein C-Reference-Cited by-同舟云学术

An early favorable outcome of streptococcal toxic shock syndrome may require a combination of antimicrobial and intravenous gamma globulin therapy together with activated protein C

Published:2006-01 Issue:11-12 Volume:38 Page:960-963
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Cone Lawrence A.,Stone Richard A.,Schlievert Patrick M.,Sneider Ronald A.,Rubin Andrew M.,Jesser Kenneth,Renker Stacey W.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00365540500373224

Reference25 articles.

1. Clinical and Bacteriologic Observations of a Toxic Shock–like Syndrome Due toStreptococcus pyogenes

2. Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A

3. 'Toxic Strep Syndrome'

4. Severe Invasive Group A Streptococcal Infections In Ontario, Canada: 1987-1991

5. Defining the Group A Streptococcal Toxic Shock Syndrome

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review;Cureus;2021-01-21

2. Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH);Antimicrobial Agents and Chemotherapy;2017-11

3. Role of intravenous immune globulin in streptococcal toxic shock syndrome andClostridium difficileinfection;American Journal of Health-System Pharmacy;2015-06-15

4. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome;FEBS Journal;2011-05-19

5. A Single, Engineered Protein Therapeutic Agent Neutralizes Exotoxins from Both Staphylococcus aureus and Streptococcus pyogenes;Clinical and Vaccine Immunology;2010-11